Les statistiques montrent que le vaccin ne tue pas, plutôt le contraire. Il est difficile de savoir si c'est parce que les vaccinés ont moins de chance d'être immunodéprimés, si c'est parce que les anti-vax prennent généralement plus de risques, voire une autre cause ou l'ensemble de ces raisons . Le taux de mortalité des populations vaccinés est globalement inférieur à celui des populations non vaccinées, y compris concernant les morts non attribuées à la COVID.
After excluding COVID-19–associated deaths, overall SMRs after dose 1 were 0.42 and 0.37 per 100 person-years for Pfizer-BioNTech and Moderna, respectively, and were 0.35 and 0.34, respectively, after dose 2 (Table 2). These rates were lower than the rate of 1.11 per 100 person-years among the unvaccinated mRNA vaccine comparison group (p <0.001). Among Janssen vaccine recipients, the overall SMR was 0.84 per 100 person-years, lower than the rate of 1.47 per 100 person-years among the unvaccinated comparison group (p <0.001). Among persons aged 12–17 years, SMRs were similar among the Pfizer-BioNTech vaccine recipients and unvaccinated comparison groups (p = 0.68 after dose 1 and 0.89 after dose 2). SMRs were also similar between Janssen vaccine recipients and unvaccinated comparison groups among Asian persons (p = 0.11). Among other subgroups defined by vaccine received, age, sex, and race and ethnicity, COVID-19 vaccine recipients had lower SMRs than did their unvaccinated counterparts (p <0.05).
[^] # Re: pente glissante
Posté par Psychofox (Mastodon) . En réponse au journal Covid 19 2 - Bogdanov 0. Évalué à 2.
Les statistiques montrent que le vaccin ne tue pas, plutôt le contraire. Il est difficile de savoir si c'est parce que les vaccinés ont moins de chance d'être immunodéprimés, si c'est parce que les anti-vax prennent généralement plus de risques, voire une autre cause ou l'ensemble de ces raisons . Le taux de mortalité des populations vaccinés est globalement inférieur à celui des populations non vaccinées, y compris concernant les morts non attribuées à la COVID.
After excluding COVID-19–associated deaths, overall SMRs after dose 1 were 0.42 and 0.37 per 100 person-years for Pfizer-BioNTech and Moderna, respectively, and were 0.35 and 0.34, respectively, after dose 2 (Table 2). These rates were lower than the rate of 1.11 per 100 person-years among the unvaccinated mRNA vaccine comparison group (p <0.001). Among Janssen vaccine recipients, the overall SMR was 0.84 per 100 person-years, lower than the rate of 1.47 per 100 person-years among the unvaccinated comparison group (p <0.001). Among persons aged 12–17 years, SMRs were similar among the Pfizer-BioNTech vaccine recipients and unvaccinated comparison groups (p = 0.68 after dose 1 and 0.89 after dose 2). SMRs were also similar between Janssen vaccine recipients and unvaccinated comparison groups among Asian persons (p = 0.11). Among other subgroups defined by vaccine received, age, sex, and race and ethnicity, COVID-19 vaccine recipients had lower SMRs than did their unvaccinated counterparts (p <0.05).
https://www.cdc.gov/mmwr/volumes/70/wr/mm7043e2.htm